Therapeutic potential of active stent coating

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomaterials Science

Background:

• Coronary artery disease treatment frequently involves stent implantation, which is superior to balloon angioplasty for significant stenosis.
• Restenosis, the re-narrowing of arteries, remains a significant limitation of coronary stenting procedures.
• Stent coating technology has emerged to address the challenge of restenosis.

Purpose of the Study:

• To review the development and clinical implementation of coated stents.
• To evaluate the efficacy and potential risks associated with active stent coatings.
• To highlight the importance of drug dosage and release kinetics in preventing restenosis.

Main Methods:

• Review of clinical studies and randomized trials on stent implantation and coating.
• Classification of coatings into passive and active types based on their mechanism of action.
• Analysis of immunosuppressive and cytostatic agents used in active coatings.

Main Results:

• Stent coatings, particularly active coatings using drugs, have demonstrated successful clinical implementation.
• Optimized drug dosage and release kinetics are critical for effective restenosis prevention.
• Potential risks include impaired re-endothelialization, leading to late-stent thrombosis.

Conclusions:

• Stent coating technology offers a promising approach to significantly reduce restenosis rates.
• Careful consideration of drug properties and release profiles is essential to mitigate risks like late-stent thrombosis.
• The advancement of coated stents represents a significant development in interventional cardiology.